BTK-IN-26 (compound 18) is a potent inhibitor of Bruton's tyrosine kinase ( BTK ) and its C481 mutant, with IC 50 values of 0.7 and 0.8 nM for BTK and BTK C481S , respectively. BTK-IN-26 can be used for cancer and autoimmune diseases research.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Btk
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.